MedPath

Study of Endothelial Keratoplasty Outcomes

Not Applicable
Completed
Conditions
Fuchs' Endothelial Corneal Dystrophy
Bullous Keratopathy
Posterior Polymorphous Dystrophy
Iridocorneal Endothelial Syndrome
Interventions
Procedure: endothelial keratoplasty
Registration Number
NCT00800111
Lead Sponsor
Cornea Research Foundation of America
Brief Summary

Endothelial keratoplasty is a cornea-sparing transplant technique that replaces only the diseased endothelial cell layer of the patient's cornea. This technique offers many advantages compared with traditional full-thickness cornea transplants. Patients experience minimal change in glasses prescription and usually recover useful vision within weeks. Visual fluctuations are minimal during the healing process. The patient's cornea remains structurally intact and is more resistant to injury.

Endothelial keratoplasty is undergoing rapid and widespread adoption. Between 2005 and 2007, the number of corneas placed by US eye banks for endothelial keratoplasty increased ten-fold (2007 Eye Bank Association of America Annual Report). However, the procedure is less than 10 years old, and little is known about long term outcomes. Endothelial keratoplasty candidates at our center are invited to participate in an open enrollment, prospective study of the long-term outcomes of this procedure.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
2593
Inclusion Criteria
  • Male or female aged 18 or older
  • Scheduled to undergo endothelial keratoplasty
  • Able to provide written informed consent.
Exclusion Criteria
  • Age less than 18 years

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Treatmentendothelial keratoplastyEndothelial keratoplasty procedure is performed.
Primary Outcome Measures
NameTimeMethod
Visual acuity1, 3, 6, and 12 months and annually
Secondary Outcome Measures
NameTimeMethod
Endothelial cell density6 months, 12 months and annually
Intraocular pressure1, 3, 6, 12 months and annually
Manifest refraction1, 3, 6, 12 months and annually
corneal pachymetry1, 3, 6, 12 months and annually

Trial Locations

Locations (1)

Price Vision Group

🇺🇸

Indianapolis, Indiana, United States

© Copyright 2025. All Rights Reserved by MedPath